Evidence map›Paper›PMID 36384820›Full record

ArticleBJPsych open2022

Lithium in the prevention of suicide in adults: systematic review and meta-analysis of clinical trials.

Natalie B Riblet, Brian Shiner, Yinong Young-Xu, Bradley V Watts

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BJPsych open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04446468 (Prevention of Suicide in Veterans Through Brief Intervention and Contact), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04446468 nacompletednot on this map

Prevention of Suicide in Veterans Through Brief Intervention and Contact (VA-BIC)

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2021 to 2025Enrolled92ConditionsSuicide PreventionArmsPEACE, Standard Psychiatric Hospital Discharge Care
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. History of Suicide Prevention with Lithium Treatment.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Natalie B RibletVeterans Affairs Medical Center, White River Junction, Vermont, USA; and Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA.ORCID https://orcid.org/0000-0001-5967-0883
Brian ShinerVeterans Affairs Medical Center, White River Junction, Vermont, USA; Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA; and National Center for PTSD, White River Junction, Vermont, USA.
Yinong Young-XuVeterans Affairs Medical Center, White River Junction, Vermont, USA; and Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA.
Bradley V WattsVeterans Affairs Medical Center, White River Junction, Vermont, USA; Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA; and Veterans Rural Health Resource Center, Veterans Affairs Medical Center, White River Junction, Vermont, USA.ORCID https://orcid.org/0000-0003-2397-6359
Dartmouth College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controversy exists regarding the efficacy of lithium for suicide prevention. Except for a recent trial that enrolled over 500 patients, available trials of lithium for suicide prevention have involved small samples. It is challenging to measure suicide in a single randomised controlled trial (RCT). Adding a single large study to existing meta-analyses may provide insights into lithium's anti-suicidal effects. We performed a meta-analysis of RCTs comparing lithium with a control condition for suicide prevention. MEDLINE and other databases were searched up to 30 November 2021. Efficacy was assessed by calculating the summary Peto odds ratio (OR) and incidence rate ratio (IRR) with 95% confidence intervals. Among seven RCTs, the odds of suicide were lower among patients receiving lithium versus control (OR = 0.30, 95% CI 0.09-1.02; IRR = 0.22, 95% CI 0.05-1.05), although the findings were still not statistically significant. The role of lithium in suicide prevention remains uncertain.

Indexed as

anti-manic agentsLithiumrandomised controlled trialssuicide preventionsystematic review

Identifiers

PMID36384820
PMCPMC9707499
OpenAlexW4309367584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.